The cyclin-dependent kinases form complexes with their cyclin partners and with CDK inhibitors. CDK6 and CDK4 associate with the D-type cyclins and target the retinoblastoma protein, allowing passage through the G1/S phase restriction point.
產品性質
別名 |
CDK 6; Cell division protein kinase 6; Crk 2; Cyclin dependent kinase 6; p40; PLSTIRE; STQTL11 |
SwissProt ID |
Q00534 |
基因ID |
1021 |
免疫原 |
A synthetic peptide of human Cdk6. |
緩沖液 |
50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40% Glycerol, 0.01% Sodium azide and 0.05% BSA. |
分子量 |
Calculated MW: 37 kDa; Observed MW: 37 kDa. |
克隆類型 |
Monoclonal Antibody |
亞型 |
IgG |
宿主 |
Rabbit |
物種反應 |
Human |
推薦應用 |
WB, ICC/IF |
純化方式 |
Affinity Purified |
應用
稀釋比 WB:1/500-1/1000; IF:1/50-1/200
儲存條件
-25~-15℃保存
注意事項
1. 避免反復凍融。
2. 本產品僅作科研用途。
3. 為了您的安全和健康,請穿實驗服并佩戴一次性手套操作。
產品數(shù)據
Western blot
Western blot analysis of CDK6 in K562, HeLa lysates using CDK6 antibody.
Ver.CN20231220